NCT07131644View on ClinicalTrials.gov

Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 13, 2025

Primary Completion Date

September 1, 2027

Study Completion Date

February 1, 2028

Conditions
Kaposiform Hemangioendothelioma
Interventions
DRUG

Sirolimus

Comparison of different sirolimus discontinuation strategies.

Trial Locations (1)

610041

West China Hospital of Sichuan University, Chengdu

All Listed Sponsors
lead

West China Hospital

OTHER

NCT07131644 - Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma | Biotech Hunter | Biotech Hunter